CAS 1033622-38-6

Fórmula: C20H17NO4

InChI: InChI=1S/C20H17NO4/c1-2-11-21(12-19(22)23)20(24)25-13-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h1,3-10,18H,11-13H2,(H,22,23)

Clave InChI: BTHZEMFPZILBCR-UHFFFAOYSA-N

SMILES: C#CCN(CC(=O)O)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)(Prop-2-Yn-1-Yl)Amino)Acetic Acid

CAS: 1033622-38-6

Fórmula: C₂₀H₁₇NO₄

Pureza: 97%

Forma y color: Solid

Peso molecular: 335.3533

Ref: IN-DA00HA1T

2-({[(9h-fluoren-9-yl)methoxy]carbonyl}(prop-2-yn-1-yl)amino)acetic acid

CAS: 1033622-38-6

2-({[(9h-fluoren-9-yl)methoxy]carbonyl}(prop-2-yn-1-yl)amino)acetic acid

Fórmula: C₂₀H₁₇NO₄

Pureza: 97%

Peso molecular: 335.35

Ref: 54-OR80863

Fmoc-N-(propargyl)-glycine

CAS: 1033622-38-6

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(prop-2-yn-1-yl)amino)acetic acid

Fórmula: C₂₀H₁₇NO₄

Pureza: 98%

Peso molecular: 335.35

Ref: IN-DG389507

Fmoc-N-(propargyl)-glycine

CAS: 1033622-38-6

Fórmula: C₂₀H₁₇NO₄

Pureza: 97%

Peso molecular: 335.359

Ref: 10-F494303

Fmoc-N-(propargyl)-glycine

CAS: 1033622-38-6

Fmoc-N-(propargyl)-glycine (Fmoc-PG) is a synthesized and modified amino acid that can be used in the treatment of cancer. Fmoc-PG has been shown to inhibit the growth of tumor cells when conjugated with positron emission radiotracers, such as 18F-Fluorodeoxyglucose, for use in positron emission tomography. Fmoc-PG also inhibits the glucose analogue, which may lead to an improvement of neurological function. Fmoc-PG has been shown to be metabolized by acid conjugates and conjugates, resulting in increased stability and reduced toxicity.

Fórmula: C₂₀H₁₇NO₄

Pureza: Min. 95%

Peso molecular: 335.36 g/mol

Ref: 3D-IRB62238